* 11 percent of babies born premature in 2010, 1.1 million died * Experts estimate 75 percent could be saved * U.S. rate at 12 pct, fueled by later births, fertility treatments NEW YORK, May 2 (Reuters) - The world's developed countries have seen their average rate of premature births double to 6 percent since 1995, despite efforts to reduce the phenomenon, according to a report released on Wednesday. Worldwide, 15 million of the...

India joins global drug discovery league The launch by Ranbaxy last week of Synriam, a new drug to treat Malaria, is an important milestone. Having made its name by manufacturing generic (off patent) drugs cheaply, India’s pharmaceutical industry has struggled to achieve original drug discovery since the Uruguay Round of trade negotiations signalled the onset of product patents in India. It began to be realised, in time, that there was...

-The Telegraph An Indian pharmaceutical company has tweaked and tested a synthetic molecule first created in an American university and developed the world's latest drug against Malaria, an alternative to standard anti-Malarial therapy. India’s Ranbaxy Laboratories today launched the new drug for the treatment of uncomplicated Malaria caused by the Plasmodium falciparum parasite, after nine years of research which was partly supported by the Indian government. Clinical trials in India, Tanzania, and Thailand...

Arundhati has got it all wrong—the facts speak out against her romantic notions of the tribals’ fight Nirad C. Chaudhary wrote in The Continent of Circe that India’s tribals were mainly found in hill forests. This was because, he reasoned, they had been chased there by the invading Aryans, who displaced them from their river plains. In an essay published in this magazine (Capitalism: A Ghost Story, March 26), Arundhati Roy...

India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...